LLY - Eli Lilly & Co.

Day 1m 10m 60m PreMarket Market AfterHours Gap
1043.8 17.74 (1.7%) -1.25 (-0.12%) -2.73 (-0.26%) -1.34 (-0.13%) -2.81 (-0.27%) 20.54 (1.97%) 0.75 (0.07%) -3.26 (-0.31%)

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
6.3
Diluted EPS:
6.29
Basic P/E:
168.4976
Diluted P/E:
168.7655
RSI(14) 1m:
53.69
VWAP:
1062.22
RVol:

Events

Period Kind Movement Occurred At

Related News